Sign inLaunch App
BTC——·ETH——·GOLD——·NVDA——·SPCX——·SP500——·CC——·BTC——·ETH——·GOLD——·NVDA——·SPCX——·SP500——·CC——·
Company pair · Health
VS

Abridge vs Zocdoc

Health Both private US-headquartered No Canborsa market

This comparison puts Abridge next to Zocdoc within health on size, funding and trajectory.

On this pageSide by sideValuation marksWhat each disclosesVerdictFAQ
AbridgePRIVATE · US
ZocdocPRIVATE · US
VS
Last valuation$5.3B$1.8B
Basis Post-money Post-money
As ofApr 2026Aug 2015
Founded20182007
Employees≈200≈1,474
On CanborsaNo marketNo market
At a glance
$5.3B
AbridgePost-money, Series E extension · Apr 2026
$1.8B
ZocdocPost-money, Funding round · Aug 2015
2.94×
GapBoth post-money, 128 months apart
0 of 2
On CanborsaNeither company has a market
VS
Head-to-head · field by field

Abridge vs Zocdoc — side by side

Field
AbridgePRIVATE · FOUNDED 2018
ZocdocPRIVATE · FOUNDED 2007
VS
Last valuation
$5.3B Post-money
$1.8B Post-money
Valuation date
1 Apr 2026
1 Aug 2015
Valuation basis
Post-money
Post-money
Latest round
Series E extension
Funding round
Round size
$316M
$130M
Round lead
Andreessen Horowitz, Khosla Ventures
Goldman Sachs, Founders Fund
Named investors
Andreessen Horowitz IVP Elad Gil Lightspeed Venture Partners
Khosla Ventures Jeff Bezos Marc Benioff Goldman Sachs
Founded
2018
2007
Employees (est.)
≈200
≈1,474
Sector & HQ
Healthcare technology and AI (AI-powered clinical documentation) · 🇺🇸 US
Telemedicine / medical appointment booking · 🇺🇸 US
Status & market
Private — no Canborsa market
Private — no Canborsa market
Valuation · both companies on one scale

Valuation marks

Each bar is the last disclosed mark — $5.3B for Abridge (post-money, Apr 2026) and $1.8B for Zocdoc (post-money, Aug 2015).

Abridge
$5.3BPost-money · Apr 2026
Zocdoc
$1.8BPost-money · Aug 2015
ABRIDGE · $5.3B · APR 2026ZOCDOC · $1.8B · AUG 2015
Abridge vs Zocdoc · what each company discloses

What each company discloses, and what it leaves out

AbridgePRIVATEHealth · US · 2018
+Last disclosed mark $5.3B — post-money, Apr 2026.
+Founded 2018 .
+≈200 employees.
+Latest round: Series E extension, $316M raised, led by Andreessen Horowitz.
ZocdocPRIVATEHealth · US · 2007
+Last disclosed mark $1.8B — post-money, Aug 2015.
+Founded 2007 .
+≈1,474 employees.
+Latest round: Funding round, $130M raised, led by Goldman Sachs.
Verdict

Verdict

The $5.3B tells you…
What an investor paid for newly issued shares — a primary round, priced post-money.
How much capital arrived with it:$316M, led by Andreessen Horowitz in Apr 2026.
A dated print: it moves only when a newer round is announced.
The $1.8B tells you…
What an investor paid for newly issued shares — a primary round, priced post-money.
How much capital arrived with it:$130M, led by Goldman Sachs in Aug 2015.
A dated print: it moves only when a newer round is announced.

Both marks are post-money, so 2.94× compares like with like. Both are private: there is no public quote and no Canborsa market on either name.

Frequently asked questions

What sector is Abridge in compared to Zocdoc?›

Abridge operates in Healthcare technology and AI (AI-powered clinical documentation), and Zocdoc operates in Telemedicine / medical appointment booking.

Which is worth more, Abridge or Zocdoc?›

Abridge was last valued at $5.3B in April 2026, and Zocdoc at $1.8B in August 2015.

Who are the lead investors in Abridge and Zocdoc?›

Abridge's lead investors include Andreessen Horowitz and Khosla Ventures, and Zocdoc's include Goldman Sachs and Founders Fund.

How many employees do Abridge and Zocdoc have?›

Abridge has about 200 employees, and Zocdoc has about 1,474.

Same pillar · company pairs

Neighbouring pairs in this sector

Alloy Therapeutics vs Commurecompany pair · health›
$7Btop valuation7.0×gap
Abridge vs Neuralinkcompany pair · health›
$9Btop valuation1.7×gap
Alloy Therapeutics vs HeartFlowcompany pair · health›
$1.6Btop valuation1.6×gap
Abridge vs Innovaccercompany pair · health›
$5.3Btop valuation1.5×gap
Abridge vs Commurecompany pair · health›
$7Btop valuation1.3×gap
Benchling vs Signoscompany pair · health›
$6.1Btop valuation6.1×gap
Calyxo vs Egenesiscompany pair · health›
$684.6Mtop valuation2.0×gap
Abridge vs Alloy Therapeuticscompany pair · health›
$5.3Btop valuation5.3×gap
Keep exploring
More pairs in Health
Abridge vs HistoSonicscompare · versus›Abridge vs HeartFlowcompare · versus›Alloy Therapeutics vs Zocdoccompare · versus›Benchling vs Kry (Livi)compare · versus›All company comparisonsindex›
Learn
Stock perps vs tokenized stocksconcept›RWA perpetualsmarkets · index›Perpetuals vs futuresconcept›What is a perpetual?guide · perpetuals basics›All Learn guideslearn · index›
Listed on Canborsa
SpaceX (SPCX)US equity · perp›Cerebras Systems (CBRS)US equity · perp›NVIDIA (NVDA)US equity · perp›Microsoft (MSFT)US equity · perp›All 86 marketsindex›
Company pair · Health

Trade 86 markets on Canborsa

© Canborsa 2026TermsPrivacy